Company City State 3 W LLC MYRTLE BEACH SC 4 Consulting
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Making the Right Move
MAKING THE RIGHT MOVE Investing and Creating Jobs in the Pittsburgh Region REAL PITTSBURGH REAL PEOPLE Looking Ahead: 2014 and Beyond Imagining a Bright Future for Our Region – and Making it Happen By Charles E. Bunch In many ways, the Pittsburgh region has com- Boomers. We’re seeing this on our job search engine within Imag- pleted the economic, environmental and qual- inePittsburgh.com, where the number of open jobs across the 10- ity-of-life transformation begun 30 years ago. county Pittsburgh region numbered around 25,000 at last count. We bottomed out in 1983, with an unemploy- ment rate over 18 percent. Throughout 2013, The Conference is addressing this opportunity in a variety of ways, in- WHEN YOU INVEST IN THE cluding through our robust talent attraction and retention initiative, COMMUNITY, THE RETURNS our jobless rate outperformed the state and the nation as a whole. We’re closing the year with the largest workforce which includes ImaginePittsburgh.com. We’re also working with ARE GUARANTEED. in regional history – about 100,000 more people employed than at our partners in workforce development to increase the supply of trained At Huntington, we know how important it is to give back to workers in the region. One such program, ShaleNET, has been such the community. After all, we do more than just work here – we industrial peak in 1979. live and raise our families here too. And after everything this a success that the federal government has increased its investment to community has done for us, we’re just happy to be able to We are enjoying the fruits of three decades of hard work by countless expand it to other states. -
Hy Sun Missed the Pharma Rally: the Answer Is Hidden in a Bet Many Failed — Speciality Drugs - the Economic Times
12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets News Industry RISE Politics Wealth MF Tech Jobs Opinion NRI Panache ET NOW More Aayush English Edition | E-Paper Tech Consumer Markets Corporate Governance Telecom + OTT Auto + Aviation Pharma Fintech + BFSI Economy Infra Environment Energy Business News › Prime › Pharma › Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Getty Images MARKETS hy Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Dilip Shanghvi, founder and managing director, Sun Pharmaceuticals Synopsis Sun Pharma is the only Indian company to have made some inroads into speciality drugs. What worries investors is high investments and uncertainties over ramp up in revenue. The stock can still see upside because of its current valuations, strong India business, and any positive surprises in US generic business. But it is crucial that its speciality bet pays off. BACK TO TOP https://economictimes.indiatimes.com/prime/pharma-and-healthcare/why-sun-missed-the-pharma-rally-the-answer-is-hidden-in-a-bet-many-failed-spe… 1/11 12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets NeCwasllI nitd uas trbyleRssISiEngP oilniti cdsisWgeuailthse fMoFr tTheceh InJodbisanOpinion NRI Panache ET NOW More pharmaceutical industry. The stocks of pharma companies have been on a tear since the beginning of the Covid-19 crisis. -
The Gendered Construction of Korean Community in Junction City, KS*
The Gendered Construction of Korean Community in Junction City, KS* Kim Sang JoㆍChung Hyejin [Abstract] This paper seeks to go beyond the received conception that Korean immigration to the US is just East-West coastal phenomena, by examining the lived experiences of Korean military brides and Korean communities in Kansas. It focuses on the dynamic community-building process of KMBs and other Korean immigrants in the Junction City-Fort Riley area. In so doing, the paper aims to illuminate how the Korean community by KMBs had been a part of the larger Junction City and Fort Riley community in Kansas, despite the negative reception and treatment that Korean immigrants, especially KMBs had to endure. It also pays a special attention to the Korean cultural values that KMBs have transmitted to their children and the local community. This paper seeks ultimately to uncover the unrecognized history of Korean migration to Kansas in what appears to be a constructed official history of Korean diaspora in Kansas. More importantly, it hopes to illuminate how to understand the Junction City Korean community is to understand the broader Korean immigrant demographic and settlement patterns now found in the military cities in the Midwest and Southwest. * This study was supported by the Research Program funded by the Seoul National University of Science and Technology 344 영미연구 제37집 Key Words: Korean Americans, Korean immigration, diaspora, gender, oral history I. Background The major history of Korean immigration to Kansas began with Korean military brides (KMBs) who married American servicemen and followed their American husbands when they completed their tour of duty. -
Pharmaceutical Cluster in Andhra Pradesh
Pharmaceutical Cluster in Andhra Pradesh Microeconomics of Competitiveness Final Project Harvard Business School Helene Herve | Lhakpa Bhuti | Saurabh Agarwal | Sonny Kushwaha | Akbar Causer May 2013 Table of Contents 1 Executive Summary ............................................................................................................................ 3 2 Introduction to India ........................................................................................................................... 4 2.1 History and Political Climate ....................................................................................................... 5 2.2 Competitive Positioning of India ................................................................................................. 6 2.2.1 Endowments .......................................................................................................................... 6 2.2.2 Economic Performance To-Date and Macroeconomic Policy .............................................. 7 2.2.3 Summary of Export Clusters ................................................................................................. 9 2.2.4 Social Infrastructure and Political Institutions .................................................................... 10 2.2.5 India Diamond .................................................................................................................... 11 3 Andhra Pradesh ................................................................................................................................ -
Nifty Poised to Open Gap up on Strong Payroll Data
Saturday, August 22, 2020 Last Week Index Performance Index Open High Low Close NIFTY CASH 11249 11460 11144 11372 Performing Sector: IT And SMALL CAP 5432 5686 5357 5659 Pharma BANK NIFTY 21907 22419 21403 22300 As per the previous one-month performance, sectors like IT has shown a growth of 28.33%, with top-performing stocks like MPhasis, Hexaware, HCL Tech, Infosys, etc. Pharma has shown an increment by 21.88%, with stocks like Divis Lab, Alkem Laboratories, IPCA, Abbot India, etc. Among the Minor sectors like Packaging, Defence and Construction, Supplies & Fixtures have shown a growth of 32.23%, 29.38% and 21.70% respectively. In the current week, Nifty opened at 11248 today. It went up to 11458 and closed at 11371 yesterday. Indian Cash Market Index, Nifty Small Cap opened at 5432 this week, made a weekly high of 5686 and closed at 5659. The major players of the market, FII & PRO together hold a net position of (-) 31419 contracts in Index Option as on 21st August 2020. Nifty and Bank Nifty Trend indicate “Buy-Bias” but can switch to “Sell Bias” or “Buy” swiftly. On the Global front, in the current week the US Index, S&P 500 opened at 3386, went up to 3400 and closed near its high at 3397. Hong Kong Benchmark Index, Hang Seng opened at 25007, made a weekly high of 25605 and closed at 25113. The Japan Benchmark Index, Nikkei opened at 23022 and closed at 22920. To get in-depth knowledge and details about Nifty Open Interest, subscribe to our app Value Stocks and schedule a one-to-one Free Training of the App https://bit.ly/33oDHML or the website www.valuestocks.in. -
Directory of American Bridge-Building Companies 1840-1900 Occasional
Back cover illustration: the heroic name plaque of Australia's Hawksbury River Bridge (1886-1946), its only surviving fabric. Photograph by D. Fraser, New South Wales. TABLE OF CONTENTS Page FOREWORD The Society for Industrial Archeology is pleased to publish this valuable d artifacts of the icant examples of search on the American brid great builder Darnell's wo important par business, and As f the Society a While active in business he also took part in civic organizations and still is a Trustee of the New Britain Museum of American Art where he had been Chairman for nine years. Since retiring, Darnel1 has intensified his study of the development of bridges in which he combines an interest in history with the training and experience of a professional engineer and steel fabricator. His article Lenticular Bridges from East Berlin. Connnecticut appeared in IA, the journal of the SIA, and he contributed to Connecticut-An Inventory of Historic Engineering and Industrial Sites. INDEX Abbott, Job See Wrought Iron Bridge Company Canton, Ohio Abbott-Gamble Contracting Company St. Louis, Missouri Adams, (J.D.) and Company Indianapolis, Indiana Agawam Foundry Springfield, Massachusetts Alabama Bridge and Boiler Company Birmingham, Alabama Alabama Bridge Company Jasper, Alabama Alabama Bridge and Iron Company Appendix C Albany Bridge and Iron Works Albany, New York Albany Iron and Machine Works Albany, New York Albany Iron Works Albany, New York Albree, Chester B. Allegheny, Pennsylvania Albuquerque Bridge Company Albuquerque , New Mexico Alden, -
United States Court of Appeals for the Federal Circuit ______
Case: 16-1973 Document: 3-2 Page: 1 Filed: 07/20/2017 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff-Appellant v. ZYDUS PHARMACEUTICALS USA, INC., CADILA HEALTHCARE, LIMITED, MYLAN INC., MYLAN PHARMACEUTICALS INC., TORRENT PHARMACEUTICALS LIMITED, TORRENT PHARMA INC., HETERO LABS LIMITED, AJANTA PHARMA LIMITED, AJANTA PHARMA USA INC., AUROBINDO PHARMA LTD., INTAS PHARMACEUTICALS LIMITED, ACCORD HEALTHCARE, INC., AUROBINDO PHARMA USA INC., AUROLIFE PHARMA LLC, LUPIN LIMITED, LUPIN ATLANTIS HOLDINGS S.A., LUPIN PHARMACEUTICALS, INC., ALEMBIC PHARMACEUTICALS LIMITED, AMNEAL PHARMACEUTICALS, LLC, AMNEAL PHARMACEUTICALS INDIA PVT. LTD., Defendants-Appellees ______________________ 2016-1962, 2016-1963, 2016-1964, 2016-1966, 2016-1968, 2016-1970, 2016-1971, 2016-1972, 2016-1973, 2016-1974, 2016-1975, 2016-1978 ______________________ Appeals from the United States District Court for the District of New Jersey in Nos. 1:14-cv-03168-JBS-KMW, Case: 16-1973 Document: 3-2 Page: 2 Filed: 07/20/2017 1:14-cv-04508-JBS-KMW, 1:14-cv-04671-JBS-KMW, 1:14- cv-05876-JBS-KMW, 1:14-cv-06158-JBS-KMW, 1:14-cv- 06890-JBS-KMW, 1:14-cv-07105-JBS-KMW, 1:14-cv- 07252-JBS-KMW, 1:14-cv-07405-JBS-KMW, 1:14-cv- 08074-JBS-KMW, 1:14-cv-08077-JBS-KMW, 1:15-cv- 01585-JBS-KMW, Chief Judge Jerome B. Simandle. ______________________ JUDGMENT ______________________ PAUL WILLIAM BROWNING, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for plaintiff-appellant. Also represented by JAMES B. MONROE, CHARLES THOMAS COLLINS-CHASE, ERIC JAY FUES, ANDREA DENISE MAIN; JEFFREY ANDREW FREEMAN, Atlanta, GA. -
Aurobindo Pharma Stock Recommendation
Aurobindo Pharma Stock Recommendation andElwin fostered. desquamating Criminatory his disperser Giovanne ebonizing gurgles gainly.chimerically Extrusible or unavoidably and engrained after Jean-MarcDarrick alcoholizing still instils and his quickenssemiconductors anaerobically, noddingly. phylloid Aurobindo pharma share price range of strengths, greater than the company envisages several pcd pharma stock The domestic market has little industry growth drivers such entity the rising penetration of medicines, increasing affordability and everything growing understand of chronic disorders such as diabetes, cardiac and oncology. How do i buy stock on vanguard etrade drip fractional shares. Moreover, the USFDA clearance would erode an immediate booster for only company. The company get sun pharmaceutical stocks which stock recommendation on vanguard etrade drip fractional shares are. Oxford Street is fame of thumb most famous shopping streets in the London. Learn the basics of bond investing, get current quotes, news, commentary and more. Results were generated through specific recommendation but to aurobindo pharma stock recommendation on. Full Name please be of string. Data provided by EDGAR Online. Try our suggested matches or see results in other tabs. Pharmaceutical company profile. Ecppa and many more a pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India, LLC of. Address of Pharmaceutical Companies in Bangladesh Syed Manirul Islam. Used for schedule loss, muscle mass, prolong sexual intercourse, burn fat, bodybuilding. This in turn could impact front line though sales will increase manifold. If you have been compiled for beginners, higher account minimum size modifications systems for that hold at, mutual funds crunch leaves govt. Scores indicate decile rank compare to index or region. -
INDIA OUTBOUND T&A Consulting Volume 6 Issue 4 3Rd April, 2017
INDIA OUTBOUND T&A Consulting Volume 6 Issue 4 3rd April, 2017 As the Financial Year comes to an end so has an eventful The trend among Indian pharma firms of “building brands“ quarter. With the liquidity shock of de-monetization having been continued, with Aurobindo Pharma adding to its portfolio of managed and a healthy, albeit counter-intuitive GDP data biosimilars acquired from a Swiss firm and leveraging market (annualised GDP growth at 7.0% for Oct-Dec Qtr) having access across specialized therapeutic segments provided by a established the soundness of macroeconomic fundamentals, the Portugese generics firm. Also active was Piramal Enterprises, high for the current Government came in the form of results for acquiring the drug portfolio of UK-based Mallinckrodt LLC to reach a the Uttar Pradesh elections. The win for the Bhartiya Janata targeted segment across eight European markets. Sun Pharma and Party in U.P. has consolidated its hold at the Centre and across Zydus Cadilla were active in North America, with Zydus acquiring a India. What that means going forward is further stability on US drug firms for a sizeable cheque to bolster its specialty India’s policy front. Case in point has been the Government’s pharmaceuticals segment whilst Sun Pharma acquired a small push in the on-going budget session of Parliament to meet the Canadian drug discovery firm. On the IT front, the bigger boys of Indian July 2017 deadline in implementing the Goods and Services IT were active acquiring assets in Latin America and their preferred market Tax. The outbound investment story nevertheless continues - United States. -
B-410032.4; B-410032.5; B-410032.6, Booz Allen Hamilton, Inc.; Leidos Inc
Comptroller General of the United States United States Government Accountability Office DOCUMENT FOR PUBLIC RELEASE Washington, DC 20548 The decision issued on the date below was subject to a GAO Protective Order. This redacted version has been approved for public release. Decision Matter of: Booz Allen Hamilton, Inc.; Leidos Inc. File: B-410032.4; B-410032.5; B-410032.6 Date: March 16, 2015 Kara M. Sacilotto, Esq., Rand L. Allen, Esq., Tracye Winfrey Howard, Esq., and George E. Petel, Esq., Wiley Rein LLP, for Booz Allen Hamilton, Inc.; and James J. McCullough, Esq., Jerald S. Howe, Jr., Esq., Michael J. Anstett, Esq., Samuel W. Jack, Esq., and Aaron T. Tucker, Esq., Fried, Frank, Harris, Shriver & Jacobson LLP, for Leidos, Inc., the protesters. Gerard F. Doyle, Esq., and Ron R. Hutchinson, Esq., Doyle & Bachman LLP, for L-3 National Security Solutions, Inc., the intervenor. LTC Gregory J. Fike, Max D. Houtz, Esq., and Gregory A. Moritz, Esq., Defense Intelligence Agency, for the agency. Eric M. Ransom, Esq., and Jennifer Westfall-McGrail, Esq., Office of the General Counsel, GAO, participated in the preparation of the decision. DIGEST Protest alleging that the agency unreasonably and disparately evaluated the vendors’ proposals and failed to follow the solicitation’s tradeoff criteria is denied where the agency’s evaluation and source selection was reasonable and consistent with the solicitation. DECISION Booz Allen Hamilton, Inc., of McLean, Virginia, and Leidos, Inc., of Reston, Virginia (the incumbent), protest the issuance of a task order to L-3 National Security Solutions, Inc., of Reston, Virginia, by the Defense Intelligence Agency (DIA), under task order request for proposals (TORP) No. -
A Collaborative Trans-Regional R&D Strategy for the South Korea Green New Deal to Achieve Future Mobility
sustainability Article A Collaborative Trans-Regional R&D Strategy for the South Korea Green New Deal to Achieve Future Mobility Doyeon Lee and Keunhwan Kim * Division of Data Analysis, Korea Institute of Science and Technology Information (KISTI), 66, Hoegi-ro, Dongdaemun-gu, Seoul 02456, Korea; [email protected] * Correspondence: [email protected] Abstract: In response to the COVID-19 pandemic, South Korea is moving to establish a national industry strategy to reduce regional inequalities within the country through the Green New Deal. Thus, it is important to closely integrate the aim of reducing greenhouse gas emissions from the Green New Deal with that of reducing deepening regional inequality from the Regionally Balanced New Deal. To accomplish these dual aims, this study provides a collaborative trans-regional R&D strategy and a precise framework with three key dimensions: regional, technological, and organizational. We demonstrate that future mobility is the most important project of the Green New Deal, comprising 1963 nationally funded projects worth USD 1285.4 million. We also illustrate the level of government investment in nationally funded research projects related to future mobility for 17 different regions and seven different technology clusters related to future mobility, and determine which research organizations played an important role in each cluster for all 17 regions between 2015 and 2020. Our results indicate that the capital region and Daejeon have high innovation capability in many future mobility-related research fields, whereas some regions have capabilities in specific research fields such as hydrogen infrastructure, indicating their relative competitiveness. Citation: Lee, D.; Kim, K. -
Investments in the Fourth Industrial Revolution
THE NATIONAL SECURITY INNOVATION BASE: INVESTMENTS IN THE FOURTH INDUSTRIAL REVOLUTION Foreword by Chris Taylor, CEO COMPANIES INCLUDED AASKI Technology Inc. ERAPSCO Red River Inc. Abbott Laboratories (ABT) Esri RELX Group (RELX) Accenture PLC (ACN) Falcon Fuels Inc. Research Triangle Institute ActioNet Inc. FCN Inc. Rockwell Collins Inc. (COL) ADS Tactical Inc. FEi Systems Safran SA (SAF) AECOM (ACM) Fluor Corp. (FLR) SAIC Corp. (SAIC) Aerojet Rocketdyne Inc. (AJRD) Four Points Technology LLC Sanofi Pasteur (SNY) AeroVironment Inc. (AVAV) Fred Hutchinson Cancer Research Center SAP SE (SAP) AI Solutions Inc. Galois Inc. Savannah River AKESOgen Inc. General Atomics Inc. Science Systems and Applications Inc. Alion Science & Technology Corp. General Dynamics Corp. (GD) Serco Inc. American Type Culture Collection GlaxoSmithKline PLC (GSK) SGT Inc. Analytic Services Inc. Great Lakes Dredge & Dock Corp. Siemens Corp. (SIE) Analytical Mechanics Associates Inc. Harris Corp. Sierra Lobo Inc. Aptima Inc. Hewlett-Packard Co. (HPQ) Sigma Space Corp. Archer Western Aviation Partners Honeywell International Inc. (HON) Smartronix Inc. Arctic Slope Regional Corp. HRL Laboratories Soar Technology Inc. Astrazeneca PLC (AZN) Huntington Ingalls (HII) Sprint Corp. (S) AT&T Inc. (T) HydroGeoLogic Inc. Technologies Forensic AURA International Business Machines Corp. (IBM) Teledyne Technologies Inc. BAE Systems Inc. (BA) immixGroup Inc. Textron (TXT) Balfour Beatty PLC (BBY) InfoReliance Corp. The Shaw Group (CBI) Ball Aerospace & Technologies Corp. Insight Public Sector Inc. (NSIT) The Walsh Group Co. Battelle Memorial Institute Intelligent Automation Inc. Thermo Fisher Scientific (TMO) Bell-Boeing JP Intelligent Software Solutions Inc. Thomson Reuters Corp. (TRI) Boeing Co. (BA) Iridium Communications Inc. (IRDM) Torch Technologies Inc. Booz Allen Hamilton Inc.